Dr. Daniel Rosenberg

Chair, Cancer Biology, Health Net, Inc.
Investigator, University of Connecticut Health Center

Dr. Daniel W. Rosenberg of the University of Connecticut Health Center, Farmington, Connecticut, shares his research work using laser capture microdissection to define early neoplasia in the colon. This includes examination of microdissected lesions in colonic research samples for molecular alterations and how these alterations may predict future risk of cancer.

In this webinar we’ll discuss:

  • Current thinking regarding chemoprevention
  • Research approaches and targets associated with colon cancer research
  • Use of laser capture microdissection in the study of genomic changes over time

Speaker bio

Dr. Daniel Rosenberg has more than 25 years of experience in the field of cancer biology. He is presently the Health Net, Inc. Chair in Cancer Biology and an Investigator in the Center for Molecular Medicine at the University of Connecticut Health Center, directing an active research program that focuses on colorectal carcinogenesis and inflammation-related cancers, using both mouse genetic models and human biospecimens for understanding early molecular changes that contribute to colon cancer risk. He is particularly interested in the development of chemoprevention strategies and nutritional interventions that can be applied to human populations. He has established a translational research program in Cancer Prevention that is formally associated with the Neag Cancer Center and he serves as the Program Director. The research interests of the Program extends across several areas of colon cancer biology, with translational applications in prevention and early detection of premalignant lesions as a primary focus.

Enter your information to register for the on-demand webinar.

*
*
*
*
*
*